Literature DB >> 11502204

Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants.

K Yuasa1, T Ohgaru, M Asahina, K Omori.   

Abstract

We have isolated and characterized rat cyclic nucleotide phosphodiesterase (PDE)11A, which exhibits properties of a dual-substrate PDE, and its splice variants (RNPDE11A2, RNPDE11A3, and RNPDE11A4). The deduced amino-acid sequence of the longest form of rat PDE11A splice variant, RNPDE11A4, was 94% identical with that of the human variant (HSPDE11A4). Rat PDE11A splice variants were expressed in a tissue-specific manner. RNPDE11A4 showed unique tissue distribution distinct from HSPDE11A4, which is specifically expressed in the prostate. Rat PDE11A splice variants were expressed in COS-7 cells, and their enzymatic characteristics were compared. Although the Km values for cAMP and cGMP were similar for all of them (1.3-1.6 and 2.1-3.9 microM, respectively), the Vmax values differed significantly (RNPDE11A4 >> RNPDE11A2 > RNPDE11A3). Human PDE11A variants also displayed very similar Km values and significantly different Vmax values (HSPDE11A4 >> HSPDE11A2 > HSPDE11A3 >> HSPDE11A1). The Vmax values of HSPDE11A4 for cAMP and cGMP were at least 100 times higher than those of HSPDE11A1. These observations indicate unique characteristics of PDE11A splicing variants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502204     DOI: 10.1046/j.1432-1327.2001.02366.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  cGMP-dependent kinase regulates response sensitivity of the mouse on bipolar cell.

Authors:  Josefin Snellman; Scott Nawy
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

2.  Activation of PDE10 and PDE11 phosphodiesterases.

Authors:  Ronald Jäger; Corina Russwurm; Frank Schwede; Hans-Gottfried Genieser; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

3.  Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples.

Authors:  Qing-Rong Liu; Tomas Drgon; Donna Walther; Catherine Johnson; Oxanna Poleskaya; Judith Hess; George R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-09       Impact factor: 11.205

Review 4.  Phosphodiesterases and adrenal Cushing in mice and humans.

Authors:  E Szarek; C A Stratakis
Journal:  Horm Metab Res       Date:  2014-09-18       Impact factor: 2.936

Review 5.  A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.

Authors:  Michy P Kelly
Journal:  Adv Neurobiol       Date:  2017

Review 6.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

7.  Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.

Authors:  Michele P Kelly; Sheree F Logue; Julie Brennan; Jonathon P Day; Subha Lakkaraju; Lixin Jiang; Xiaotian Zhong; May Tam; Stacey J Sukoff Rizzo; Brian J Platt; Jason M Dwyer; Sarah Neal; Virginia L Pulito; Michael J Agostino; Steven M Grauer; Rachel L Navarra; Cody Kelley; Thomas A Comery; Richard J Murrills; Miles D Houslay; Nicholas J Brandon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

8.  Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.

Authors:  Katy Pilarzyk; Latarsha Porcher; William R Capell; Steven D Burbano; Jeff Davis; Janet L Fisher; Nicole Gorny; Siena Petrolle; Michy P Kelly
Journal:  Aging Cell       Date:  2022-09-08       Impact factor: 11.005

9.  Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.

Authors:  S A Boikos; A Horvath; S Heyerdahl; E Stein; A Robinson-White; I Bossis; J Bertherat; J A Carney; C A Stratakis
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

10.  Design and Microwave Assisted Synthesis of Coumarin Derivatives as PDE Inhibitors.

Authors:  Mahadev N Kumbar; Ravindra R Kamble; Atulkumar A Kamble; Sujith Raj Salian; Sandhya Kumari; Ramya Nair; Guruprasad Kalthur; Satish Kumar Adiga; D Jagadeesh Prasad
Journal:  Int J Med Chem       Date:  2016-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.